I found this release this morning and was also VERY INTRIGUEDhere is another take on it
https://www.xda-developers.com/samsung-exynos-w920-wearable-chip-detailed/Wear OS-powered smartwatches have historically remained quite underwhelming in terms of battery life and performance. But there’s been a renewed push to turn the situation around with Google and Samsung teaming up to redesign the Wear OS platform and Qualcomm vowing to develop new chips designed for wearables from the ground up.
.
The upcoming Galaxy Watch 4 series will serve as the perfect opportunity to assess whether these efforts have really paid off. Not only the Galaxy Watch 4 will be the first smartwatch to run the unified Wear OS platform, but it’ll also feature the most cutting-edge wearable chip we have seen on a Wear OS smartwatch. But Samsung isn’t waiting for its Galaxy Unpacked event to tell us all about its new wearable chip. Ahead of the mega launch event on Wednesday, Samsung has detailed the Exynos W920.
.The Exynos W920 is Samsung’s newest wearable chip, and it will be powering both models of the Galaxy Watch 4 — or at least that’s what all leaks and evidence are suggesting. The Exynos W920 is built on a 5nm (nanometer) extreme ultra-violate (EUV) process, and that alone is quite impressive and should bring massive efficiency improvements.
.
It employs two ARM Cortex-A55 cores and ARM Mali-G68 GPU. Samsung claims up to 20% improved CPU performance and ten times better graphics performance than the Exynos W9110, which came out three years ago. For context, Qualcomm’s flagship wearable chip, Snapdragon Wear 4100 Plus, is built on a 12nm process and features four Cortex-A53 cores.
.
Although the Exynos W920 has fewer CPU cores, the faster Cortex-A55 cores and efficient 5nm process mean it should easily blow the Snapdragon Wear 4100+ out of the water as far as performance and battery life are concerned.
- Forums
- ASX - By Stock
- BRN
- 2021 BRN Discussion
2021 BRN Discussion, page-18710
-
-
- There are more pages in this discussion • 14,871 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $361.9M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $878.2K | 4.371M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
64 | 1444914 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 388739 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
62 | 1344164 | 0.195 |
62 | 1739410 | 0.190 |
33 | 1759832 | 0.185 |
50 | 1530443 | 0.180 |
16 | 598862 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 337097 | 7 |
0.205 | 914687 | 15 |
0.210 | 1398298 | 25 |
0.215 | 506951 | 23 |
0.220 | 758461 | 24 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online